These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 12494174)
1. [Beta-adrenoblockers: evidence based principles of therapy]. Martsevich SY Kardiologiia; 2002; 42(4):82-5. PubMed ID: 12494174 [No Abstract] [Full Text] [Related]
2. [beta-Adrenoblockers: current approaches to use]. Martsevich SIu Ter Arkh; 2002; 74(1):67-70. PubMed ID: 11878066 [No Abstract] [Full Text] [Related]
3. [The place of β-adrenoblockers in the treatment of cardiovascular disease in patients with chronic obstructive pulmonary disease]. Statsenko ME; Derevianchenko MV Kardiologiia; 2012; 52(12):57-63. PubMed ID: 23237442 [TBL] [Abstract][Full Text] [Related]
4. [beta-Adrenoblockers in cardiology: metoprolol succinate]. Zateĭshchikov DA; Dankovtseva EN Kardiologiia; 2007; 47(8):87-92. PubMed ID: 18260921 [No Abstract] [Full Text] [Related]
5. [Pleiotropic effects of beta-adrenoblockers in the therapy of cardiovascular diseases: effect on lipid peroxidation, endothelial function, and evolution of atherosclerosis]. Sitnikova MIu; Ivanov SG; Khmel'nitskaia KA Kardiologiia; 2009; 49(6):61-6. PubMed ID: 19656097 [TBL] [Abstract][Full Text] [Related]
6. Clinical inquiries. Do beta-blockers worsen respiratory status for patients with COPD? Baselli LM; Oswald MA; Nashelsky JM J Fam Pract; 2005 May; 54(5):472-3. PubMed ID: 15865911 [No Abstract] [Full Text] [Related]
7. [Practical approaches to selection of beta-adrenoblocker for the treatment of cardiovascular diseases: novel evidence based data]. Giliarevskiĭ SR Kardiologiia; 2006; 46(11):79-85. PubMed ID: 17183752 [No Abstract] [Full Text] [Related]
8. [Are all beta-adrenoblockers equally effective? Place of carvedilol in the treatment of cardiovascular diseases]. Tereshchenko SN; Zhirov IV Ter Arkh; 2007; 79(4):86-90. PubMed ID: 17564027 [No Abstract] [Full Text] [Related]
9. [What has changed in therapy of vascular patients (role of statins and beta-adrenoblockers)]. Pokrovskiĭ AV; Goloviuk AL Angiol Sosud Khir; 2010; 16(2):7-11. PubMed ID: 21032867 [TBL] [Abstract][Full Text] [Related]
16. Prescription drugs uses and effect. Beta blockers. Cardiovascular disease. Jordan S; Knight J Nurs Stand; 2004 Aug 18-24; 18(49):suppl 1-2. PubMed ID: 15478259 [No Abstract] [Full Text] [Related]
17. Esmolol: a novel ultra-short acting beta-adrenoreceptor blocking agent. Singh BN; Laddu AR Ration Drug Ther; 1986 Aug; 20(8):1-7. PubMed ID: 2882545 [No Abstract] [Full Text] [Related]
18. Therapeutic scope of beta-adrenergic blocking agents. Canale JM; Horwitz S Arch Invest Med (Mex); 1979; 10(4):261-77. PubMed ID: 44180 [No Abstract] [Full Text] [Related]
19. The use of beta adrenergic blocking drugs in cardiovascular disease. Prichard BN Scott Med J; 1976 Oct; 21(4):182-7. PubMed ID: 11558 [No Abstract] [Full Text] [Related]
20. [Beta-blockers. Value in cardiovascular diseases]. Feuring M; Schmidt BM; Christ M; Wehling M Internist (Berl); 1999 Jun; 40(6):680-5. PubMed ID: 10420326 [No Abstract] [Full Text] [Related] [Next] [New Search]